BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8901526)

  • 1. Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes.
    Willems GM; Janssen MP; Pelsers MM; Comfurius P; Galli M; Zwaal RF; Bevers EM
    Biochemistry; 1996 Oct; 35(43):13833-42. PubMed ID: 8901526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient high affinity binding of tissue factor pathway inhibitor-factor Xa complexes to negatively charged phospholipid membranes.
    Willems GM; Janssen MP; Salemink I; Wun TC; Lindhout T
    Biochemistry; 1998 Mar; 37(10):3321-8. PubMed ID: 9521652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding.
    Roubey RA; Eisenberg RA; Harper MF; Winfield JB
    J Immunol; 1995 Jan; 154(2):954-60. PubMed ID: 7814895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes.
    Willems GM; Janssen MP; Comfurius P; Galli M; Zwaal RF; Bevers EM
    Biochemistry; 2000 Feb; 39(8):1982-9. PubMed ID: 10684648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
    Wagenknecht DR; McIntyre JA
    Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies.
    Del Papa N; Sheng YH; Raschi E; Kandiah DA; Tincani A; Khamashta MA; Atsumi T; Hughes GR; Ichikawa K; Koike T; Balestrieri G; Krilis SA; Meroni PL
    J Immunol; 1998 Jun; 160(11):5572-8. PubMed ID: 9605162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets.
    Shi W; Chong BH; Hogg PJ; Chesterman CN
    Thromb Haemost; 1993 Aug; 70(2):342-5. PubMed ID: 8236146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
    Arvieux J; Roussel B; Colomb MG
    Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
    Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
    J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strength of Ca(2+) binding to retinal lipid membranes: consequences for lipid organization.
    Huster D; Arnold K; Gawrisch K
    Biophys J; 2000 Jun; 78(6):3011-8. PubMed ID: 10827979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
    Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
    Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome.
    Galazka MW; Keil LB; Kohles J; Petersheim M; DeBari VA
    Ann Clin Lab Sci; 1998; 28(3):153-9. PubMed ID: 9646856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
    Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
    Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of prothrombin-mediated binding of lupus anticoagulant antibodies to phosphatidylserine-containing phospholipid membranes: an ellipsometric study.
    Willems GM; Janssen MP; Comfurius P; Galli M; Zwaal RF; Bevers EM
    Biochemistry; 2002 Dec; 41(48):14357-63. PubMed ID: 12450402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
    Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
    Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.